Log in

OTCMKTS:BGMDBG Medicine Stock Price, Forecast & News

$0.02
+0.00 (+15.79 %)
(As of 08/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.02
Now: $0.02
$0.03
50-Day Range
$0.02
MA: $0.02
$0.03
52-Week Range
$0.01
Now: $0.02
$0.05
Volume4,750 shs
Average Volume3,025 shs
Market Capitalization$250,000.00
P/E RatioN/A
Dividend YieldN/A
Beta0.77
BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.
Read More
BG Medicine logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryLife Sciences Tools & Services
SectorMedical
Current SymbolOTCMKTS:BGMD
Previous SymbolNASDAQ:BGMD
CUSIP08861T10
Phone781-890-1199

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees5
Market Cap$250,000.00
Next Earnings DateN/A
OptionableNot Optionable
$0.02
+0.00 (+15.79 %)
(As of 08/10/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BGMD News and Ratings via Email

Sign-up to receive the latest news and ratings for BGMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











BG Medicine (OTCMKTS:BGMD) Frequently Asked Questions

How has BG Medicine's stock been impacted by COVID-19 (Coronavirus)?

BG Medicine's stock was trading at $0.0151 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BGMD stock has increased by 45.7% and is now trading at $0.0220.
View which stocks have been most impacted by Coronavirus
.

How were BG Medicine's earnings last quarter?

BG Medicine, Inc. (OTCMKTS:BGMD) released its earnings results on Tuesday, November, 17th. The medical research company reported ($0.27) earnings per share for the quarter. The medical research company earned $334 million during the quarter, compared to analyst estimates of $695 million.
View BG Medicine's earnings history
.

Has BG Medicine been receiving favorable news coverage?

Media stories about BGMD stock have trended somewhat negative on Tuesday, InfoTrie Sentiment reports. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. BG Medicine earned a daily sentiment score of -1.9 on InfoTrie's scale. They also assigned media headlines about the medical research company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days.
View the latest news about BG Medicine
.

Are investors shorting BG Medicine?

BG Medicine saw a drop in short interest in the month of December. As of December 31st, there was short interest totaling 100 shares, a drop of 87.5% from the December 15th total of 800 shares. Based on an average trading volume of 59,000 shares, the short-interest ratio is currently 0.0 days.
View BG Medicine's Short Interest
.

Who are some of BG Medicine's key competitors?

What other stocks do shareholders of BG Medicine own?

Who are BG Medicine's key executives?

BG Medicine's management team includes the following people:
  • Dr. Paul R. Sohmer, CEO, Pres & Director (Age 70)
  • Mr. Stephen P. Hall, CFO, Exec. VP & Treasurer (Age 68)
  • Dr. Aram Adourian, Chief Scientific Officer (Age 49)

What is BG Medicine's stock symbol?

BG Medicine trades on the OTCMKTS under the ticker symbol "BGMD."

How do I buy shares of BG Medicine?

Shares of BGMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is BG Medicine's stock price today?

One share of BGMD stock can currently be purchased for approximately $0.02.

How big of a company is BG Medicine?

BG Medicine has a market capitalization of $250,000.00. BG Medicine employs 5 workers across the globe.

What is BG Medicine's official website?

The official website for BG Medicine is www.bg-medicine.com.

How can I contact BG Medicine?

BG Medicine's mailing address is 303 Wyman Street Suite 300, Waltham MA, 02451. The medical research company can be reached via phone at 781-890-1199 or via email at [email protected]

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.